LONZA GROUP UNSP.ADR 1/10 Market Cap ($41.04 Billion)
Market Cap & Net Worth: LONZA GROUP UNSP.ADR 1/10 (LO3A)
LONZA GROUP UNSP.ADR 1/10 market cap. LONZA GROUP UNSP.ADR 1/10 (F:LO3A) has a market capitalization of $41.04 Billion (€35.10 Billion) as of October 31, 2026. Listed on the F stock exchange, this Germany-based company holds position #653 globally and #140 in its home market, demonstrating a -3.54% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying LONZA GROUP UNSP.ADR 1/10's stock price €54.50 by its total outstanding shares 701455510 (701.46 Million).
LONZA GROUP UNSP.ADR 1/10 Market Cap History (2019–2026)
LONZA GROUP UNSP.ADR 1/10 market cap history from 2019 to 2026. Data shows growth from $25.58 Billion to $56.18 Billion (9.98% CAGR). Check LO3A stock price for real-time trading data and today's change.
LONZA GROUP UNSP.ADR 1/10 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how LONZA GROUP UNSP.ADR 1/10's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see cash flow conversion of LONZA GROUP UNSP.ADR 1/10 for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
7.09x
LONZA GROUP UNSP.ADR 1/10's market cap is 7.09 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $37.96 Billion | $6.22 Billion | $1.22 Billion | 6.10x | 31.24x |
| 2023 | $30.25 Billion | $6.72 Billion | $654.00 Million | 4.50x | 46.25x |
| 2024 | $45.92 Billion | $5.48 Billion | $636.00 Million | 8.38x | 72.21x |
| 2025 | $46.33 Billion | $6.53 Billion | -$275.00 Million | 7.09x | N/A |
Competitor Companies of LO3A by Market Capitalization
Companies near LONZA GROUP UNSP.ADR 1/10 in the global market cap rankings as of October 31, 2026. See LONZA GROUP UNSP.ADR 1/10 (LO3A) net asset quality to understand what proportion of total assets are financed by equity.
Key companies related to LONZA GROUP UNSP.ADR 1/10 by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #87 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #136 globally with a market cap of $167.39 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #659 globally with a market cap of $40.58 Billion USD.
- Natera Inc (NASDAQ:NTRA): Ranked #480 globally with a market cap of $56.33 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $709.18 |
| #136 | Danaher Corporation | NYSE:DHR | $167.39 Billion | $236.98 |
| #659 | IDEXX Laboratories Inc | NASDAQ:IDXX | $40.58 Billion | $575.98 |
| #480 | Natera Inc | NASDAQ:NTRA | $56.33 Billion | $436.00 |
Market Capitalization of LONZA GROUP UNSP.ADR 1/10 (2019–2026)
Market capitalization of LONZA GROUP UNSP.ADR 1/10 from 2019 to today. Between 2019 and today, LONZA GROUP UNSP.ADR 1/10's market cap moved from $25.58 Billion to $ 56.18 Billion, with a yearly change of 9.98%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €56.18 Billion | +21.24% |
| 2025 | €46.33 Billion | +0.89% |
| 2024 | €45.92 Billion | +51.84% |
| 2023 | €30.25 Billion | -20.32% |
| 2022 | €37.96 Billion | -36.12% |
| 2021 | €59.42 Billion | +40.68% |
| 2020 | €42.24 Billion | +65.15% |
| 2019 | €25.58 Billion | -- |
End of Day Market Cap According to Different Sources
On Apr 24th, 2026 the market cap of LONZA GROUP UNSP.ADR 1/10 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $41.04 Billion USD |
| MoneyControl | $41.04 Billion USD |
| MarketWatch | $41.04 Billion USD |
| marketcap.company | $41.04 Billion USD |
| Reuters | $41.04 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About LONZA GROUP UNSP.ADR 1/10
Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics; Small Molecules; Cell & Gene; and Capsules & Health Ingredients segments. The Biologics segment engages in the contract develo… Read more